Table of Contents
International Journal of Molecular Imaging
Volume 2012, Article ID 189254, 13 pages
http://dx.doi.org/10.1155/2012/189254
Research Article

Quantitative Longitudinal Imaging of Vascular Inflammation and Treatment by Ezetimibe in apoE Mice by FMT Using New Optical Imaging Biomarkers of Cathepsin Activity and Integrin

1Department of Imaging, Merck Research Laboratories, 770 Sumneytown Pike, WP44C-2, West Point, PA 19486, USA
2Department of Applied Biology, Perkin Elmer, 549 Albany Street, Boston, MA 02451, USA

Received 23 April 2012; Accepted 6 September 2012

Academic Editor: Darrell R. Fisher

Copyright © 2012 Shu-An Lin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Libby, “Inflammation in atherosclerosis,” Nature, vol. 420, no. 6917, pp. 868–874, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. G. K. Hansson, “Inflammation, atherosclerosis, and coronary artery disease,” The New England Journal of Medicine, vol. 352, no. 16, pp. 1685–1695, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. G. K. Hansson and P. Libby, “The immune response in atherosclerosis: a double-edged sword,” Nature Reviews Immunology, vol. 6, no. 7, pp. 508–519, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. D. J. Rader and A. Daugherty, “Translating molecular discoveries into new therapies for atherosclerosis,” Nature, vol. 451, no. 7181, pp. 904–913, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. F. K. Swirski, M. J. Pittet, M. F. Kircher et al., “Monocyte accumulation in mouse atherogenesis is progressive and proportional to extent of disease,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 27, pp. 10340–10345, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. F. K. Swirski, P. Libby, E. Aikawa et al., “Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata,” Journal of Clinical Investigation, vol. 117, no. 1, pp. 195–205, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. K. J. Woollard and F. Geissmann, “Monocytes in atherosclerosis: subsets and functions,” Nature Reviews Cardiology, vol. 7, no. 2, pp. 77–86, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Sanz and Z. A. Fayad, “Imaging of atherosclerotic cardiovascular disease,” Nature, vol. 451, no. 7181, pp. 953–957, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. F. A. Jaffer, P. Libby, and R. Weissleder, “Optical and multimodality molecular imaging: insights into atherosclerosis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 29, no. 7, pp. 1017–1024, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. A. C. Lindsay and R. P. Choudhury, “Form to function: current and future roles for atherosclerosis imaging in drug development,” Nature Reviews Drug Discovery, vol. 7, no. 6, pp. 517–529, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. G. W. Stone, A. Maehara, A. J. Lansky et al., “A prospective natural-history study of coronary atherosclerosis,” The New England Journal of Medicine, vol. 364, no. 3, pp. 226–235, 2011. View at Google Scholar
  12. A. J. Sinusas, F. Bengel, M. Nahrendorf et al., “Multimodality cardiovascular molecular imaging, part I,” Circulation, vol. 1, no. 3, pp. 244–256, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Nahrendorf, D. E. Sosnovik, B. A. French et al., “Multimodality cardiovascular molecular imaging, Part II,” Circulation, vol. 2, no. 1, pp. 56–70, 2009. View at Google Scholar
  14. C. M. Matter, M. Stuber, and M. Nahrendorf, “Imaging of the unstable plaque: how far have we got?” European Heart Journal, vol. 30, no. 21, pp. 2566–2574, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. J. H. F. Rudd, F. Hyafil, and Z. A. Fayad, “Inflammation imaging in atherosclerosis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 29, no. 7, pp. 1009–1016, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. M. M. Sadeghi, D. K. Glover, G. M. Lanza, Z. A. Fayad, and L. L. Johnson, “Imaging atherosclerosis and vulnerable plaque,” Journal of Nuclear Medicine, vol. 51, supplement 1, pp. 51S–65S, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. D. Vancraeynest, A. Pasquet, V. Roelants, B. L. Gerber, and J. L. J. Vanoverschelde, “Imaging the vulnerable plaque,” Journal of the American College of Cardiology, vol. 57, no. 20, pp. 1961–1979, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. W. Li, X. M. Yuan, A. G. Olsson, and U. T. Brunk, “Uptake of oxidized LDL by macrophages results in partial lysosomal enzyme inactivation and relocation,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 18, no. 2, pp. 177–184, 1998. View at Google Scholar · View at Scopus
  19. A. S. Antonov, F. D. Kolodgie, D. H. Munn, and R. G. Gerrity, “Regulation of macrophage foam cell formation by αvβ3 integrin: Potential role in human atherosclerosis,” American Journal of Pathology, vol. 165, no. 1, pp. 247–258, 2004. View at Google Scholar · View at Scopus
  20. V. Y. Reddy, Q. Y. Zhang, and S. J. Weiss, “Pericellular mobilization of the tissue-destructive cysteine proteinases, cathepsins B, L, and S, by human monocyte-derived macrophages,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 9, pp. 3849–3853, 1995. View at Google Scholar · View at Scopus
  21. G. K. Sukhova, G. P. Shi, D. I. Simon, H. A. Chapman, and P. Libby, “Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells,” Journal of Clinical Investigation, vol. 102, no. 3, pp. 576–583, 1998. View at Google Scholar · View at Scopus
  22. J. Liu, G. K. Sukhova, J. S. Sun et al., “Lysosomal cysteine proteases in atherosclerosis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 8, pp. 1359–1366, 2004. View at Google Scholar
  23. A. Garcia-Touchard, T. D. Henry, G. Sangiorgi et al., “Extracellular proteases in atherosclerosis and restenosis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 6, pp. 1119–1127, 2005. View at Google Scholar
  24. S. P. M. Lutgens, K. B. J. M. Cleutjens, M. J. A. P. Daemen, and S. Heeneman, “Cathepsin cysteine proteases in cardiovascular disease,” FASEB Journal, vol. 21, no. 12, pp. 3029–3041, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. G. L. ten Kate, E. J. G. Sijbrands, R. Valkema et al., “Molecular imaging of inflammation and intraplaque vasa vasorum: a step forward to identification of vulnerable plaques?” Journal of Nuclear Cardiology, vol. 17, no. 5, pp. 897–912, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. P. R. Moreno, K. R. Purushothaman, V. Fuster et al., “Plaque neovascularization is increased in ruptured atherosclerotic lesions of human aorta: implications for plaque vulnerability,” Circulation, vol. 110, no. 14, pp. 2032–2038, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. R. Weissleder, C. H. Tung, U. Mahmood, and A. Bogdanov, “In vivo imaging of tumors with protease-activated near-infrared fluorescent probes,” Nature Biotechnology, vol. 17, no. 4, pp. 375–378, 1999. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Fujimoto, D. Hartung, S. Ohshima et al., “Molecular imaging of matrix metalloproteinase in atherosclerotic lesions. Resolution with dietary modification and statin therapy,” Journal of the American College of Cardiology, vol. 52, no. 23, pp. 1847–1857, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Chen, C. H. Tung, U. Mahmood et al., “In vivo imaging of proteolytic activity in atherosclerosis,” Circulation, vol. 105, no. 23, pp. 2766–2771, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. F. A. Jaffer, P. Libby, and R. Weissleder, “Molecular imaging of cardiovascular disease,” Circulation, vol. 116, no. 9, pp. 1052–1061, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. F. A. Jaffer, D. E. Kim, L. Quinti et al., “Optical visualization of cathepsin K activity in atherosclerosis with a novel, protease-activatable fluorescence sensor,” Circulation, vol. 115, no. 17, pp. 2292–2298, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. F. A. Jaffer, C. Vinegoni, M. C. John et al., “Real-time catheter molecular sensing of inflammation in proteolytically active atherosclerosis,” Circulation, vol. 118, no. 18, pp. 1802–1809, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. M. A. Calfon, C. Vinegoni, V. Ntziachristos, and F. A. Jaffer, “Intravascular near-infrared fluorescence molecular imaging of atherosclerosis: toward coronary arterial visualization of biologically high-risk plaques,” Journal of Biomedical Optics, vol. 15, no. 1, Article ID 011107, 2010. View at Google Scholar · View at Scopus
  34. D. E. Kim, J. Y. Kim, D. Schellingerhout et al., “Molecular imaging of Cathepsin B proteolytic enzyme activity reflects the inflammatory component of atherosclerotic pathology and can quantitatively demonstrate the antiatherosclerotic therapeutic effects of atorvastatin and glucosamine,” Molecular Imaging, vol. 8, no. 5, pp. 291–301, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. D. E. Kim, J. Y. Kim, D. Schellingerhout et al., “Protease imaging of human atheromata captures molecular information of atherosclerosis, complementing anatomic imaging,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 3, pp. 449–456, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. F. A. Jaffer, M. A. Calfon, A. Rosenthal et al., “Two-dimensional intravascular near-infrared fluorescence molecular imaging of inflammation in atherosclerosis and stent-induced vascular injury,” Journal of the American College of Cardiology, vol. 57, no. 25, pp. 2516–2526, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Nahrendorf, P. Waterman, G. Thurber et al., “Hybrid in vivo FMT-CT imaging of protease activity in atherosclerosis with customized nanosensors,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 29, no. 10, pp. 1444–1451, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. M. M. Sadeghi, S. Krassilnikova, J. Zhang et al., “Detection of injury-induced vascular remodeling by targeting activated αvβ3 integrin in vivo,” Circulation, vol. 110, no. 1, pp. 84–90, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. J. Waldeck, F. Häger, C. Höltke et al., “Fluorescence reflectance imaging of macrophage-rich atherosclerotic plaques using an αvβ3 integrin-targeted fluorochrome,” Journal of Nuclear Medicine, vol. 49, no. 11, pp. 1845–1851, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. P. M. Winter, A. M. Morawski, S. D. Caruthers et al., “Molecular imaging of angiogenesis in early-stage atherosclerosis with αvβ3-integrin-targeted nanoparticles,” Circulation, vol. 108, no. 18, pp. 2270–2274, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. I. Laitinen, A. Saraste, E. Weidl et al., “Evaluation of αvβ3 integrin-targeted positron emission tomography tracer 18F-galacto-RGD for imaging of vascular inflammation in atherosclerotic mice,” Circulation, vol. 2, no. 4, pp. 331–338, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. J. Heroux, A. M. Gharib, N. S. Danthi, S. Cecchini, J. Ohayon, and R. I. Pettigrew, “High-affinity αvβ3 integrin targeted optical probe as a new imaging biomarker for early atherosclerosis: initial studies in watanabe rabbits,” Molecular Imaging and Biology, vol. 12, no. 1, pp. 2–8, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. C. Burtea, S. Laurent, O. Murariu et al., “Molecular imaging of αvβ3 integrin expression in atherosclerotic plaques with a mimetic of RGD peptide grafted to Gd-DTPA,” Cardiovascular Research, vol. 78, no. 1, pp. 148–157, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. P. J. Kuhlencordt, P. Padmapriya, S. Rützel et al., “Ezetimibe potently reduces vascular inflammation and arteriosclerosis in eNOS-deficient ApoE ko mice,” Atherosclerosis, vol. 202, no. 1, pp. 48–57, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. K. Graf, T. Dietrich, M. Tachezy et al., “Monitoring therapeutical intervention with ezetimibe using targeted near-infrared fluorescence imaging in experimental atherosclerosis,” Molecular Imaging, vol. 7, no. 2, pp. 68–76, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. S. Kossodo, M. Pickarski, S. A. Lin et al., “Dual in vivo quantification of integrin-targeted and protease-activated agents in cancer using fluorescence molecular tomography (FMT),” Molecular Imaging and Biology, vol. 12, no. 5, pp. 488–499, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. S. H. Zhang, R. L. Reddick, J. A. Piedrahita, and N. Maeda, “Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E,” Science, vol. 258, no. 5081, pp. 468–471, 1992. View at Google Scholar · View at Scopus
  48. T. Dietrich, T. Hucko, R. Bourayou et al., “High resolution magnetic resonance imaging in atherosclerotic mice treated with ezetimibe,” International Journal of Cardiovascular Imaging, vol. 25, no. 8, pp. 827–836, 2009. View at Publisher · View at Google Scholar · View at Scopus